 | H2E | Name: | 2-morpholin-4-yl-6-[7-[(2~{R})-1-morpholin-4-ylpropan-2-yl]oxy-9~{H}-thioxanthen-4-yl]pyran-4-one | Formula: | C29 H32 N2 O5 S | SMILES: | C[CH](CN1CCOCC1)Oc2ccc3Sc4c(Cc3c2)cccc4C5=CC(=O)C=C(O5)N6CCOCC6 | InChi: | InChI=1S/C29H32N2O5S/c1-20(19-30-7-11-33-12-8-30)35-24-5-6-27-22(16-24)15-21-3-2-4-25(29(21)37-27)26-17-23(32)18-28(36-26)31-9-13-34-14-10-31/h2-6,16-18,20H,7-15,19H2,1H3/t20-/m1/s1 | Definition date: | 2018-11-08 | Last modified: | 2019-03-15 | Release date: | 2019-03-20 | Identifier: | 2-morpholin-4-yl-6-[7-[(2~{R})-1-morpholin-4-ylpropan-2-yl]oxy-9~{H}-thioxanthen-4-yl]pyran-4-one |
|
 | HEW | Name: | 4-bromanylpyridin-2-amine | Formula: | C5 H5 Br N2 | SMILES: | Nc1cc(Br)ccn1 | InChi: | InChI=1S/C5H5BrN2/c6-4-1-2-8-5(7)3-4/h1-3H,(H2,7,8) | Definition date: | 2018-12-04 | Last modified: | 2019-03-15 | Release date: | 2019-03-20 | Identifier: | 4-bromanylpyridin-2-amine |
|
 | HGH | Name: | 2-[3-[(2-azanyl-9~{H}-purin-6-yl)oxy]phenyl]ethanoic acid | Formula: | C13 H11 N5 O3 | SMILES: | Nc1nc2[nH]cnc2c(Oc3cccc(CC(O)=O)c3)n1 | InChi: | InChI=1S/C13H11N5O3/c14-13-17-11-10(15-6-16-11)12(18-13)21-8-3-1-2-7(4-8)5-9(19)20/h1-4,6H,5H2,(H,19,20)(H3,14,15,16,17,18) | Definition date: | 2018-12-06 | Last modified: | 2019-03-15 | Release date: | 2019-03-20 | Identifier: | 2-[3-[(2-azanyl-9~{H}-purin-6-yl)oxy]phenyl]ethanoic acid |
|
 | HGK | Name: | 2-[4-[(2-oxidanylidene-3~{H}-pyridin-4-yl)oxy]phenyl]ethanoic acid | Formula: | C13 H11 N O4 | SMILES: | OC(=O)Cc1ccc(OC2=CC=NC(=O)C2)cc1 | InChi: | InChI=1S/C13H11NO4/c15-12-8-11(5-6-14-12)18-10-3-1-9(2-4-10)7-13(16)17/h1-6H,7-8H2,(H,16,17) | Definition date: | 2018-12-06 | Last modified: | 2019-03-15 | Release date: | 2019-03-20 | Identifier: | 2-[4-[(2-oxidanylidene-3~{H}-pyridin-4-yl)oxy]phenyl]ethanoic acid |
|
 | HGQ | Name: | 4-bromanyl-1~{H}-pyridin-2-one | Formula: | C5 H4 Br N O | SMILES: | BrC1=CC(=O)NC=C1 | InChi: | InChI=1S/C5H4BrNO/c6-4-1-2-7-5(8)3-4/h1-3H,(H,7,8) | Definition date: | 2018-12-06 | Last modified: | 2019-03-15 | Release date: | 2019-03-20 | Identifier: | 4-bromanyl-1~{H}-pyridin-2-one |
|
 | HH5 | Name: | 6-iodanyl-7~{H}-purin-2-amine | Formula: | C5 H4 I N5 | SMILES: | Nc1nc(I)c2[nH]cnc2n1 | InChi: | InChI=1S/C5H4IN5/c6-3-2-4(9-1-8-2)11-5(7)10-3/h1H,(H3,7,8,9,10,11) | Definition date: | 2018-12-06 | Last modified: | 2019-03-15 | Release date: | 2019-03-20 | Identifier: | 6-iodanyl-7~{H}-purin-2-amine |
|
 | HH8 | Name: | 4-bromanyl-1,8-naphthyridine | Formula: | C8 H5 Br N2 | SMILES: | Brc1ccnc2ncccc12 | InChi: | InChI=1S/C8H5BrN2/c9-7-3-5-11-8-6(7)2-1-4-10-8/h1-5H | Definition date: | 2018-12-06 | Last modified: | 2019-03-15 | Release date: | 2019-03-20 | Identifier: | 4-bromanyl-1,8-naphthyridine |
|
 | HHB | Name: | 2-[3-(pyrimidin-4-ylamino)phenyl]ethanoic acid | Formula: | C12 H11 N3 O2 | SMILES: | OC(=O)Cc1cccc(Nc2ccncn2)c1 | InChi: | InChI=1S/C12H11N3O2/c16-12(17)7-9-2-1-3-10(6-9)15-11-4-5-13-8-14-11/h1-6,8H,7H2,(H,16,17)(H,13,14,15) | Definition date: | 2018-12-06 | Last modified: | 2019-03-15 | Release date: | 2019-03-20 | Identifier: | 2-[3-(pyrimidin-4-ylamino)phenyl]ethanoic acid |
|
 | KQY | Name: | 6-aminohexanamide | Formula: | C6 H14 N2 O | SMILES: | O=C(CCCCCN)N | InChi: | InChI=1S/C6H14N2O/c7-5-3-1-2-4-6(8)9/h1-5,7H2,(H2,8,9) | Definition date: | 2019-01-08 | Last modified: | 2019-03-15 | Release date: | 2019-03-20 | Identifier: | 6-aminohexanamide |
|
 | HHN | Name: | 5-bromanylpyrimidine | Formula: | C4 H3 Br N2 | SMILES: | Brc1cncnc1 | InChi: | InChI=1S/C4H3BrN2/c5-4-1-6-3-7-2-4/h1-3H | Definition date: | 2018-12-06 | Last modified: | 2019-03-15 | Release date: | 2019-03-20 | Identifier: | 5-bromanylpyrimidine |
|
 | HHQ | Name: | 4-iodanyl-3~{H}-pyridin-2-one | Formula: | C5 H4 I N O | SMILES: | IC1=CC=NC(=O)C1 | InChi: | InChI=1S/C5H4INO/c6-4-1-2-7-5(8)3-4/h1-2H,3H2 | Definition date: | 2018-12-06 | Last modified: | 2019-03-15 | Release date: | 2019-03-20 | Identifier: | 4-iodanyl-3~{H}-pyridin-2-one |
|
 | HHW | Name: | (~{E})-3-[3-[(4-chlorophenyl)carbamoyl]phenyl]prop-2-enoic acid | Formula: | C16 H12 Cl N O3 | SMILES: | OC(=O)C=Cc1cccc(c1)C(=O)Nc2ccc(Cl)cc2 | InChi: | InChI=1S/C16H12ClNO3/c17-13-5-7-14(8-6-13)18-16(21)12-3-1-2-11(10-12)4-9-15(19)20/h1-10H,(H,18,21)(H,19,20)/b9-4+ | Definition date: | 2018-12-06 | Last modified: | 2019-03-15 | Release date: | 2019-03-20 | Identifier: | (~{E})-3-[3-[(4-chlorophenyl)carbamoyl]phenyl]prop-2-enoic acid |
|
 | HJK | Name: | 2-[3-(2-azanyl-9~{H}-purin-6-yl)phenyl]ethanoic acid | Formula: | C13 H11 N5 O2 | SMILES: | Nc1nc2[nH]cnc2c(n1)c3cccc(CC(O)=O)c3 | InChi: | InChI=1S/C13H11N5O2/c14-13-17-10(11-12(18-13)16-6-15-11)8-3-1-2-7(4-8)5-9(19)20/h1-4,6H,5H2,(H,19,20)(H3,14,15,16,17,18) | Definition date: | 2018-12-10 | Last modified: | 2019-03-15 | Release date: | 2019-03-20 | Identifier: | 2-[3-(2-azanyl-9~{H}-purin-6-yl)phenyl]ethanoic acid |
|
 | KVD | Name: | 5-(phenylethynyl)pyridine-3-carboxylic acid | Formula: | C14 H9 N O2 | SMILES: | c1(ccccc1)C#Cc2cncc(C(O)=O)c2 | InChi: | InChI=1S/C14H9NO2/c16-14(17)13-8-12(9-15-10-13)7-6-11-4-2-1-3-5-11/h1-5,8-10H,(H,16,17) | Definition date: | 2019-01-18 | Last modified: | 2019-03-15 | Release date: | 2019-03-20 | Identifier: | 5-(phenylethynyl)pyridine-3-carboxylic acid |
|
 | KW1 | Name: | ({2-[(4-bromo-5-methyl-1,2-oxazol-3-yl)amino]-2-oxoethyl}sulfanyl)acetic acid | Formula: | C8 H9 Br N2 O4 S | SMILES: | C(SCC(O)=O)C(Nc1c(c(C)on1)Br)=O | InChi: | InChI=1S/C8H9BrN2O4S/c1-4-7(9)8(11-15-4)10-5(12)2-16-3-6(13)14/h2-3H2,1H3,(H,13,14)(H,10,11,12) | Definition date: | 2019-01-18 | Last modified: | 2019-03-15 | Release date: | 2019-03-20 | Identifier: | ({2-[(4-bromo-5-methyl-1,2-oxazol-3-yl)amino]-2-oxoethyl}sulfanyl)acetic acid |
|
 | KWG | Name: | 3-(phenylethynyl)-2-(1H-pyrrol-1-yl)benzoic acid | Formula: | C19 H13 N O2 | SMILES: | c3c(C#Cc1cccc(C(O)=O)c1n2cccc2)cccc3 | InChi: | InChI=1S/C19H13NO2/c21-19(22)17-10-6-9-16(18(17)20-13-4-5-14-20)12-11-15-7-2-1-3-8-15/h1-10,13-14H,(H,21,22) | Definition date: | 2019-01-21 | Last modified: | 2019-03-15 | Release date: | 2019-03-20 | Identifier: | 3-(phenylethynyl)-2-(1H-pyrrol-1-yl)benzoic acid |
|
 | HQG | Name: | [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{R},3~{S},4~{R},5~{R})-3,4-bis(oxidanyl)-5-phosphonooxy-oxolan-2-yl]methyl hydrogen phosphate | Formula: | C15 H24 N5 O17 P3 | SMILES: | C2(C(C(C(COP(O)(=O)OP(O)(=O)OCC1C(C(C(OP(=O)(O)O)O1)O)O)O2)O)O)n3c4c(nc3)c(ncn4)N | InChi: | InChI=1S/C15H24N5O17P3/c16-12-7-13(18-3-17-12)20(4-19-7)14-10(23)8(21)5(34-14)1-32-39(28,29)37-40(30,31)33-2-6-9(22)11(24)15(35-6)36-38(25,26)27/h3-6,8-11,14-15,21-24H,1-2H2,(H,28,29)(H,30,31)(H2,16,17,18)(H2,25,26,27)/t5-,6-,8-,9-,10-,11-,14-,15-/m1/s1 | Definition date: | 2018-07-16 | Last modified: | 2019-03-15 | Release date: | 2019-03-20 | Identifier: | [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl [(2R,3S,4R,5R)-3,4-dihydroxy-5-(phosphonooxy)tetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name) |
|
 | OS2 | Name: | (3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-{[(prop-2-yn-1-yl)sulfanyl]methyl}pyrrolidin-3-ol | Formula: | C15 H19 N5 O S | SMILES: | OC3CN(Cc2c1ncnc(c1nc2)N)CC3CSCC#C | InChi: | InChI=1S/C15H19N5OS/c1-2-3-22-8-11-6-20(7-12(11)21)5-10-4-17-14-13(10)18-9-19-15(14)16/h1,4,9,11-12,17,21H,3,5-8H2,(H2,16,18,19)/t11-,12+/m1/s1 | Definition date: | 2018-07-03 | Last modified: | 2019-03-15 | Release date: | 2019-03-20 | Identifier: | (3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-{[(prop-2-yn-1-yl)sulfanyl]methyl}pyrrolidin-3-ol |
|
 | OS3 | Name: | (3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-{[(pent-4-yn-1-yl)sulfanyl]methyl}pyrrolidin-3-ol | Formula: | C17 H23 N5 O S | SMILES: | Nc1c2ncc(c2ncn1)CN3CC(O)C(C3)CSCCCC#C | InChi: | InChI=1S/C17H23N5OS/c1-2-3-4-5-24-10-13-8-22(9-14(13)23)7-12-6-19-16-15(12)20-11-21-17(16)18/h1,6,11,13-14,19,23H,3-5,7-10H2,(H2,18,20,21)/t13-,14+/m1/s1 | Definition date: | 2018-07-03 | Last modified: | 2019-03-15 | Release date: | 2019-03-20 | Identifier: | (3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-{[(pent-4-yn-1-yl)sulfanyl]methyl}pyrrolidin-3-ol |
|
 | OS5 | Name: | (3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-({[3-(1-benzyl-1H-1,2,3-triazol-4-yl)propyl]sulfanyl}methyl)pyrrolidin-3-ol | Formula: | C24 H30 N8 O S | SMILES: | OC3CN(Cc1cnc2c1ncnc2N)CC3CSCCCc4nnn(c4)Cc5ccccc5 | InChi: | InChI=1S/C24H30N8OS/c25-24-23-22(27-16-28-24)18(9-26-23)11-31-12-19(21(33)14-31)15-34-8-4-7-20-13-32(30-29-20)10-17-5-2-1-3-6-17/h1-3,5-6,9,13,16,19,21,26,33H,4,7-8,10-12,14-15H2,(H2,25,27,28)/t19-,21+/m1/s1 | Definition date: | 2018-07-03 | Last modified: | 2019-03-15 | Release date: | 2019-03-20 | Identifier: | (3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-({[3-(1-benzyl-1H-1,2,3-triazol-4-yl)propyl]sulfanyl}methyl)pyrrolidin-3-ol |
|
 | OS6 | Name: | (3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-({[3-(1-butyl-1H-1,2,3-triazol-4-yl)propyl]sulfanyl}methyl)pyrrolidin-3-ol | Formula: | C21 H32 N8 O S | SMILES: | OC1C(CN(C1)Cc3c2ncnc(N)c2nc3)CSCCCc4cn(nn4)CCCC | InChi: | InChI=1S/C21H32N8OS/c1-2-3-6-29-11-17(26-27-29)5-4-7-31-13-16-10-28(12-18(16)30)9-15-8-23-20-19(15)24-14-25-21(20)22/h8,11,14,16,18,23,30H,2-7,9-10,12-13H2,1H3,(H2,22,24,25)/t16-,18+/m1/s1 | Definition date: | 2018-07-03 | Last modified: | 2019-03-15 | Release date: | 2019-03-20 | Identifier: | (3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-({[3-(1-butyl-1H-1,2,3-triazol-4-yl)propyl]sulfanyl}methyl)pyrrolidin-3-ol |
|
 | QAS | Name: | 6-mercaptopyridine-2,3-dicarboxylic acid | Formula: | C7 H5 N O4 S | SMILES: | OC(=O)c1ccc(S)nc1C(O)=O | InChi: | InChI=1S/C7H5NO4S/c9-6(10)3-1-2-4(13)8-5(3)7(11)12/h1-2H,(H,8,13)(H,9,10)(H,11,12) | Definition date: | 2018-10-26 | Last modified: | 2019-03-15 | Release date: | 2019-03-20 | Identifier: | 6-sulfanylpyridine-2,3-dicarboxylic acid |
|
 | QAT | Name: | 5-mercaptopyridine-2,3-dicarboxylic acid | Formula: | C7 H5 N O4 S | SMILES: | OC(=O)C1=C(N=CC(=S)C1)C(O)=O | InChi: | InChI=1S/C7H5NO4S/c9-6(10)4-1-3(13)2-8-5(4)7(11)12/h2H,1H2,(H,9,10)(H,11,12) | Definition date: | 2018-10-29 | Last modified: | 2019-03-15 | Release date: | 2019-03-20 | Identifier: | 5-sulfanylidene-4~{H}-pyridine-2,3-dicarboxylic acid |
|
 | 9TO | Name: | N-(4-methoxyphenyl)-4-[3-(pyridin-3-yl)-1H-pyrazol-4-yl]pyrimidin-2-amine | Formula: | C19 H16 N6 O | SMILES: | c1ncccc1c4c(c3ccnc(Nc2ccc(OC)cc2)n3)cnn4 | InChi: | InChI=1S/C19H16N6O/c1-26-15-6-4-14(5-7-15)23-19-21-10-8-17(24-19)16-12-22-25-18(16)13-3-2-9-20-11-13/h2-12H,1H3,(H,22,25)(H,21,23,24) | Definition date: | 2018-07-30 | Last modified: | 2019-03-15 | Release date: | 2019-03-20 | Identifier: | N-(4-methoxyphenyl)-4-[3-(pyridin-3-yl)-1H-pyrazol-4-yl]pyrimidin-2-amine |
|
 | 9Z3 | Name: | N-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl-L-cysteine | Formula: | C12 H23 N2 O9 P S | SMILES: | C(=O)(C(C(C)(COP(O)(O)=O)C)O)NCCC(=O)NC(C(O)=O)CS | InChi: | InChI=1S/C12H23N2O9PS/c1-12(2,6-23-24(20,21)22)9(16)10(17)13-4-3-8(15)14-7(5-25)11(18)19/h7,9,16,25H,3-6H2,1-2H3,(H,13,17)(H,14,15)(H,18,19)(H2,20,21,22)/t7-,9-/m0/s1 | Definition date: | 2018-08-31 | Last modified: | 2019-03-15 | Release date: | 2019-03-20 | Identifier: | N-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl-L-cysteine |
|